LivaNova PLC
LIVN
Hisse Senetlerindeki Sıralama
#3841
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Hisse Fiyatı
$78.37
Piyasa Değeri
$4.31B
Değişim (1 gün)
1.02%
Değişim (1 yıl)
45.86%
Ülke
GB
Ticaret LivaNova PLC (LIVN)
Kategori
Healthcare
LivaNova PLC (LIVN) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 13.48%
LivaNova PLC şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 13.48%'dir. 2023 yılı sonunda şirketin faaliyet marjı -5.94% idi.
LivaNova PLC için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 13.48% | 30.87% |
| 2024 | 10.30% | -273.40% |
| 2023 | -5.94% | -215.12% |
| 2022 | 5.16% | -5,833.33% |
| 2021 | -0.09% | -98.03% |
| 2020 | -4.58% | -203.39% |
| 2019 | 4.43% | -119.77% |
| 2018 | -22.41% | -337.14% |
| 2017 | 9.45% | -516.30% |
| 2016 | -2.27% | -107.46% |
| 2015 | 30.41% | -1.30% |
| 2013 | 30.81% | 10.47% |
| 2012 | 27.89% | 7.98% |
| 2011 | 25.83% | 17.57% |
| 2010 | 21.97% | 66.19% |
| 2009 | 13.22% | -294.70% |
| 2008 | -6.79% | -82.05% |
| 2007 | -37.82% | -21.18% |
| 2006 | -47.98% | 284.46% |
| 2005 | -12.48% | -306.28% |
| 2004 | 6.05% | 35.04% |
| 2003 | 4.48% | -111.54% |
| 2002 | -38.81% | 0.00% |
| 2001 | 0.00% | -100.00% |
| 2000 | -10.97% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 17.03% | -98.74% |
US
|
|
| 17.86% | -98.68% |
IE
|
|
| 22.03% | -98.37% |
US
|
|
| 21.46% | -98.41% |
US
|
|
| 0.00% | - |
DE
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.